Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 155,136	$ 304,767
Restricted cash	1,463	1,472
Investments	243,022	119,543
Trade receivables	48,639	50,599
Inventory, net	27,466	27,533
Prepaid expenses and other current assets	15,157	12,586
Total current assets	490,883	516,500
Property and equipment, net	8,376	8,617
Long-term investments	3,432	18,077
Other assets	7,046	6,806
Total assets	509,737	550,000
Liabilities and Stockholders’ Deficit
Accounts payable	6,254	14,356
Accrued expenses	75,212	87,565
Deferred revenue	1,200	1,224
Lease financing obligation	2,491	2,369
Total current liabilities	85,157	105,514
Lease financing obligation	5,934	5,804
Royalty financing obligations	514,411	501,655
Secured term loan	232,522	231,624
Stockholders’ equity:
Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding	0	0
Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 188,883 as of March 31, 2023 and 187,906 as of December 31, 2022	1,889	1,879
Additional paid-in capital	1,177,192	1,158,118
Accumulated other comprehensive income	585	26
Accumulated deficit	(1,507,953)	(1,454,620)
Total stockholders’ deficit	(328,287)	(294,597)
Total liabilities and stockholders’ deficit	$ 509,737	$ 550,000